Based on 1 analyst offering 12 month price targets for Surgepays Inc
Min Forecast
$9.75+755.26%
Avg Forecast
$9.75+755.26%
Max Forecast
$9.75+755.26%
Should I buy or sell SURG stock?
Based on 1 analyst offering ratings for Surgepays Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although SURG's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates SURG as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More
Be the first to know when Wall Street analysts revise their SURG stock forecasts and price targets.
Is Surgepays Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: SURG) stock is to Buy SURG stock.
Out of 1 analyst, 0 (0%) are recommending SURG as a Strong Buy, 1 (100%) are recommending SURG as a Buy, 0 (0%) are recommending SURG as a Hold, 0 (0%) are recommending SURG as a Sell, and 0 (0%) are recommending SURG as a Strong Sell.
What is SURG's earnings growth forecast for 2026-2026?
(NASDAQ: SURG) Surgepays's forecast annual earnings growth rate of N/A is not forecast to beat the US Software - Application industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Surgepays's earnings in 2026 is -$42,019,457.
In 2026, SURG is forecast to generate $1,180,426 in earnings, with the lowest earnings forecast at -$1,855,856 and the highest earnings forecast at $4,418,706.
What is SURG's revenue growth forecast for 2026-2026?
(NASDAQ: SURG) Surgepays's forecast annual revenue growth rate of N/A is not forecast to beat the US Software - Application industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Surgepays's revenue in 2026 is $50,372,554.
In 2026, SURG is forecast to generate $2,837,861,036 in revenue, with the lowest revenue forecast at $1,739,560,209 and the highest revenue forecast at $3,979,149,555.
What is SURG's forecast return on assets (ROA) for 2026-2026?
(NASDAQ: SURG) forecast ROA is 8.14%, which is lower than the forecast US Software - Application industry average of 26.35%.
What is SURG's Price Target?
According to 1 Wall Street analyst that have issued a 1 year SURG price target, the average SURG price target is $9.75, with the highest SURG stock price forecast at $9.75 and the lowest SURG stock price forecast at $9.75.
The Wall Street analyst predicted that Surgepays's share price could reach $9.75 by Dec 22, 2026. The average Surgepays stock price prediction forecasts a potential upside of 755.26% from the current SURG share price of $1.14.
What is SURG's Earnings Per Share (EPS) forecast for 2026-2026?
(NASDAQ: SURG) Surgepays's current Earnings Per Share (EPS) is -$2.14. In 2026, SURG's EPS is forecast to hit $0.06 (min: -$0.09, max: $0.21).
What is SURG's forecast return on equity (ROE) for 2026-2026?
(NASDAQ: SURG) forecast ROE is -18.53%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.